| Date | Title | Description | Source |
| 06.11.2023 | XNK Therapeutics announces poster presentations at the 38[th... | XNK Therapeutics announces poster presentations at the 38[th] Annual Meeting of the Society for Immu... | news.cisio... |
| 14.08.2023 | XNK Therapeutics to present two posters at the NK2023 confer... | XNK Therapeutics to present two posters at the NK2023 conference in Oslo in September
Mon, Aug 14, ... | news.cisio... |
| 10.08.2023 | XNK Therapeutics enters into agreement with US-based biotech... | XNK Therapeutics enters into agreement with US-based biotechnology company
Thu, Aug 10, 2023 08:05 ... | news.cisio... |
| 07.08.2023 | XNK Therapeutics to present two abstracts at the Society for... | XNK Therapeutics to present two abstracts at the Society for Immunotherapy of Cancer’s meeting in Sa... | news.cisio... |
| 12.07.2023 | XNK Therapeutics one of three winners of Business Sweden’s C... | XNK Therapeutics one of three winners of Business Sweden’s Catalyst program 2023
Wed, Jul 12, 2023 ... | news.cisio... |
| 07.06.2023 | XNK Therapeutics appoints Hugo Petit as Chief Financial Offi... | XNK Therapeutics appoints Hugo Petit as Chief Financial Officer
Wed, Jun 07, 2023 08:05 CET Report ... | news.cisio... |
| 24.05.2023 | XNK Therapeutics to present at ABG Sundal Collier’s Life Sci... | XNK Therapeutics to present at ABG Sundal Collier’s Life Science Summit in Stockholm
Wed, May 24, 2... | news.cisio... |
| 04.05.2023 | XNK Therapeutics Enters into Research Agreement with Global ... | XNK Therapeutics Enters into Research Agreement with Global Pharma Company
Thu, May 04, 2023 08:05 ... | news.cisio... |
| 03.04.2023 | XNK Receives EU Tissue Establishment Certificate | XNK Receives EU Tissue Establishment Certificate
Mon, Apr 03, 2023 08:05 CET Report this content
X... | news.cisio... |
| 22.03.2023 | XNK presents at the 8[th] Innate Killer Summit in La Jolla, ... | XNK presents at the 8[th] Innate Killer Summit in La Jolla, San Diego
Wed, Mar 22, 2023 08:05 CET R... | news.cisio... |
| 20.03.2023 | XNK receives certificate of GMP compliance of a manufacturer... | XNK receives certificate of GMP compliance of a manufacturer from the Medical Products Agency
Mon, ... | news.cisio... |
| 21.02.2023 | XNK Therapeutics to present at Redeye’s Regenerative Medicin... | XNK Therapeutics to present at Redeye’s Regenerative Medicine/Cell Therapy event on February 22
Tue... | news.cisio... |
| 19.01.2023 | XNK Therapeutics appoints Dr. Peter Hovstadius as CMO | XNK Therapeutics appoints Dr. Peter Hovstadius as CMO
Thu, Jan 19, 2023 08:05 CET Report this conte... | news.cisio... |
| 15.12.2022 | First patient cells collected in XNK’s preclinical bladder c... | First patient cells collected in XNK’s preclinical bladder cancer study
Thu, Dec 15, 2022 09:49 CET... | news.cisio... |
| 21.11.2022 | XNK Therapeutics continues platform development work with Ad... | XNK Therapeutics continues platform development work with AdBIOPRO after Sweden’s Vinnova extends in... | news.cisio... |
| 21.11.2022 | XNK Therapeutics continues platform development work with Ad... | HUDDINGE, Sweden, Nov. 21, 2022 /PRNewswire/ -- XNK Therapeutics AB ("XNK") today said the... | einpresswi... |
| 15.09.2022 | XNK Therapeutics appoints Dr. Anna-Karin Maltais as CSO | XNK Therapeutics appoints Dr. Anna-Karin Maltais as CSO
Thu, Sep 15, 2022 08:05 CET Report this con... | news.cisio... |
| 01.09.2022 | XNK Therapeutics completes building phase of new GMP facilit... | XNK Therapeutics completes building phase of new GMP facility
Thu, Sep 01, 2022 08:05 CET Report th... | news.cisio... |
| 28.06.2022 | XNK broadens its pipeline with bladder cancer study | XNK broadens its pipeline with bladder cancer study
Tue, Jun 28, 2022 08:05 CET Report this content... | news.cisio... |
| 10.06.2022 | Positive clinical results of ACP-001 presented at EHA2022 | Positive clinical results of ACP-001 presented at EHA2022
Fri, Jun 10, 2022 16:30 CET Report this c... | news.cisio... |
| 09.05.2022 | Ted Fjällman new board member at XNK Therapeutics | Ted Fjällman new board member at XNK Therapeutics
Mon, May 09, 2022 08:05 CET Report this content
... | news.cisio... |
| 02.05.2022 | XNK Therapeutics gets abstract on ACP-001 selected for prese... | XNK Therapeutics gets abstract on ACP-001 selected for presentation at EHA2022
Mon, May 02, 2022 08... | news.cisio... |
| 29.03.2022 | XNK Therapeutics raises SEK 132 million to accelerate growth | XNK Therapeutics raises SEK 132 million to accelerate growth
Tue, Mar 29, 2022 08:05 CET Report thi... | news.cisio... |
| 23.03.2022 | XNK Therapeutics Reports First Patient Treated in Phase II S... | XNK Therapeutics Reports First Patient Treated in Phase II Study in Multiple Myeloma
Wed, Mar 23, 2... | news.cisio... |
| 22.02.2022 | XNK Therapeutics to present at Redeye’s Regenerative Medicin... | XNK Therapeutics to present at Redeye’s Regenerative Medicine/Cell Therapy event on February 23
Tue... | news.cisio... |
| 17.02.2022 | Clinical study published regarding XNK Therapeutics’ NK cell... | Clinical study published regarding XNK Therapeutics’ NK cell-based product
Thu, Feb 17, 2022 08:05 ... | news.cisio... |
| 20.12.2021 | XNK Therapeutics strengthens its scientific network with two... | XNK Therapeutics strengthens its scientific network with two more advisors Mon, Dec 20, 2021 08:10 C... | news.cisio... |
| 06.12.2021 | XNK Therapeutics announces study in acute myeloid leukemia (... | XNK Therapeutics announces study in acute myeloid leukemia (AML) patient samples Mon, Dec 06, 2021 0... | news.cisio... |
| 01.12.2021 | XNK Therapeutics to present at ABGSC Private Companies Semin... | XNK Therapeutics to present at ABGSC Private Companies Seminar on December 6 Wed, Dec 01, 2021 08:05... | news.cisio... |
| 16.11.2021 | XNK Therapeutics adds three scientific advisors to bolster p... | XNK Therapeutics adds three scientific advisors to bolster platform technology Tue, Nov 16, 2021 08:... | news.cisio... |
| 29.09.2021 | XNK Therapeutics targets broader pipeline opportunities for ... | XNK Therapeutics targets broader pipeline opportunities for its NK cell therapy Wed, Sep 29, 2021 08... | news.cisio... |
| 15.09.2021 | Dr. David Berglund and Dr. Stephen Wooding nominated as new ... | Dr. David Berglund and Dr. Stephen Wooding nominated as new board members at XNK Therapeutics Wed, S... | news.cisio... |
| 03.09.2021 | XNK Therapeutics appoints Markus Thor as Chief Business Offi... | XNK Therapeutics appoints Markus Thor as Chief Business Officer Fri, Sep 03, 2021 08:05 CET
Sept. 3... | news.cisio... |
